Outset Medical
138 hedge funds and large institutions have $760M invested in Outset Medical in 2022 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 52 increasing their positions, 41 reducing their positions, and 28 closing their positions.
27% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 41
5% more capital invested
Capital invested by funds: $721M → $760M (+$38.2M)
0.13% less ownership
Funds ownership: 6.76% → 6.63% (-0.13%)
7% less funds holding
Funds holding: 149 → 138 (-11)
36% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 28
87% less call options, than puts
Call options by funds: $229K | Put options by funds: $1.79M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$13M |
| 2 |
PVI
Pura Vida Investments
New York
|
+$8.23M |
| 3 |
NCGI
Next Century Growth Investors
Plymouth,
Minnesota
|
+$7.5M |
| 4 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$4.77M |
| 5 |
CWG
C WorldWide Group
Copenhagen,
Denmark
|
+$4.46M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$50.2M |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$18.7M |
| 3 |
Barclays
London,
United Kingdom
|
-$10.7M |
| 4 |
Allspring Global Investments
Charlotte,
North Carolina
|
-$10.7M |
| 5 |
TCM
TimesSquare Capital Management
New York
|
-$6.96M |
OM Hedge Fund Activity: Q3 2022 in Review
138 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Outset Medical (OM) for Q3 2022, worth a combined $760M — up 5.3% from $721M a quarter earlier.
Sellers outnumbered buyers: 28 funds closed out of OM and 18 opened new positions — a net loss of 10 holders — while 41 trimmed existing stakes and 52 added.
The largest buyer was PFM Health Sciences, opening a new position worth an estimated $13M. The largest seller was T. Rowe Price Associates, cutting an estimated $50.2M.
- 138 institutional investors held Outset Medical (OM) as of Q3 2022, down from 149 in Q2 2022.
- Funds reported $760M of Outset Medical stock for Q3 2022, up 5.3% quarter-over-quarter.
- 18 funds opened new Outset Medical positions in Q3 2022 and 28 closed out, a net change of -10 holders.
- The largest Outset Medical buyer in Q3 2022 was PFM Health Sciences, an estimated $13M added.
- The largest Outset Medical seller in Q3 2022 was T. Rowe Price Associates, an estimated $50.2M sold.
Based on aggregated 13F filings for Q3 2022.